Send to

Choose Destination
Pathol Res Pract. 2017 Aug;213(8):874-881. doi: 10.1016/j.prp.2017.05.005. Epub 2017 May 19.

15 years of the histopathological synovitis score, further development and review: A diagnostic score for rheumatology and orthopaedics.

Author information

MVZ-Zentrum für Histologie, Zytologie und Molekulare Diagnostik, Trier, Germany. Electronic address:
Department of Pathology and Laboratory Medicine, Hospital for Special Surgery, New York, USA.
Klinik und Poliklinik für Orthopädie, Universitätsklinikum Hamburg-Eppendorf, Germany.
MVZ-Zentrum für Histologie, Zytologie und Molekulare Diagnostik, Trier, Germany.
Pathologisch-bakteriologisches Institut, Otto Wagner Spital, Vienna, Austria.
Hôpital Orthopédique, Lausanne, Switzerland.
Rhumatologie, Centre hospital-universitaire de Nantes, France.
TWINCORE, Zentrum für Experimentelle und Klinische Infektionsforschung GmbH, Hannover, Germany; Helmholtz-Zentrum für Infektionsforschung, Braunschweig, Germany.
Medizinische Universität Wien, AKH-Wien, Universitätsklinik für Orthopädie, Vienna, Austria.
MVZ-Zentrum für Histologie, Zytologie und Molekulare Diagnostik, Trier, Germany; Proteopath GmbH, Trier, Germany.
Proteopath GmbH, Trier, Germany.
Med. Klinik, Rheumatologie und Klinische Immunologie (Charité),Berlin, Germany.
VMscope-Berlin, Germany.
Paracelsus-Kliniken Deutschland, Osnabrück, Germany.
Orthopädische Universitätsklinik Erlangen, Erlangen, Germany.
Medizinische Universität Graz - Institut für Pathologie, Austria.
Vreden Russian Scientific Research Institute of Traumatology and Orthopedics, Saint Petersburg, Russia.
MVZ Fürstenberg-Karree, Berlin, Germany.


The histopathological synovitis score evaluates the immunological and inflammatory changes of synovitis in a graduated manner generally customary for diagnostic histopathological scores. The score results from semiquantitative evaluation of the width of the synovial surface cell layer, the cell density of the stroma and the density of the inflammatory infiltration into 4 semiquantitative levels (normal 0, mild 1, moderate 2, severe 3). The addition of these values results in a final score of 0-9 out of 9. On the basis of this summation the condition is divided into low-grade synovitis and high-grade synovitis: A synovitis score of 1 to≤4 is called low-grade synovitis (arthrosis-associated/OA synovitis, posttraumatic synovitis, meniscopathy-associated synovitis and synovitis with haemochromatosis). A synovitis score of≥5 to 9 is called high-grade synovitis (rheumatoid arthritis, psoriatic arthritis, Lyme arthritis, postinfection/reactive arthritis and peripheral arthritis with Bechterew's disease). By means of the synovitis score it is therefore possible to distinguish between degenerative/posttraumatic diseases (low-grade synovitis) and inflammatory rheumatic diseases (high-grade synovitis) with a sensitivity of 61.7% and a specificity of 96.1%. The diagnostic accuracy according to ROC analysis (AUC: 0.8-0.9) is good. Since the first publication (2002) and an associated subsequent publication (2006), the synovitis score has nationally and internationally been accepted for histopathological assessment of the synovitis. In a PubMed data analysis (status: 14.02.2017), the following citation rates according to Cited by PubMed Central articles resulted for the two synovitis score publications: For DOI: 10.1078/0344-0338-5710261 there were 29 Cited by PubMed Central articles and for the second extended publication DOI:10.1111/j.1365-2559.2006.02508 there were 44 Cited by PubMed Central articles. Therefore a total of 73 PubMed citations are observed over a period of 15 years, which demonstrates an international acceptance of the score. This synovitis score provides for the first time a diagnostic, standardised and reproducible histopathological evaluation method enabling a contribution to the differential diagnosis of chronic inflammatory general joint diseases. This is particularly the case by incorporation into the joint pathology algorithm. To specify the synovitis score an immunohistochemical determination of various inflammation-relevant CD antigens is proposed to enable a risk stratification of high-grade synovitis (e.g.: progression risk and sensitivity for biologicals).


Arthrosis; Immunohistochemistry; Rheumatoid arthritis; Risk stratification; Semiquantitative evaluation; Synovitis; Synovitis score

[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center